Rahul Chaudhary | Medicine and Dentistry | Best Researcher Award

Dr. Rahul Chaudhary | Medicine and Dentistry | Best Researcher Award

Consultant Anesthesiologist at Birat medical college and teaching hospital, Nepal

Dr. Rahul Chaudhary is a highly accomplished anesthesiologist with over a decade of experience in managing complex cases across various medical specialties, including general surgery, orthopedics, gynecology, ophthalmology, urology, and more. He has gained specialized expertise in critical care management, particularly in trauma ICU, COVID-ICU, and pediatric anesthesia. His leadership extends to several subspecialties, such as neuroanesthesia, cardiac surgeries, robotic surgeries, and transplant surgeries. Dr. Chaudhary is known for his meticulous approach to anesthesia management, particularly for complex surgeries, including liver and renal transplants. He is also recognized for his ability to handle high-pressure situations, especially in the ICU setting, where he has managed critical and trauma patients effectively. As a researcher, educator, and clinician, Dr. Chaudhary has consistently demonstrated his commitment to improving patient outcomes and advancing the field of anesthesiology.

Professional Profile

Education

Dr. Rahul Chaudhary completed his MBBS from a reputed medical college in Nepal. He then pursued his postgraduate studies in Anaesthesia and Intensive Care at PGIMER, Chandigarh, where he earned his MD in Anesthesia. His educational journey reflects his deep commitment to medical excellence, where he focused on anesthesia management, critical care, and trauma care. Throughout his academic career, Dr. Chaudhary has been involved in several specialized training programs and certifications, including ACLS, ILS, and advanced anesthesia techniques like transesophageal echocardiography. His education has provided him with a comprehensive foundation in anesthesiology, preparing him to tackle some of the most challenging medical procedures and clinical situations.

Professional Experience

Dr. Rahul Chaudhary’s professional experience spans over several years, with significant contributions to both clinical and academic fields. He served as a Medical Officer and Chief Medical Officer at various institutions, including Rani PHC, before moving on to roles as a Consultant Anaesthesiologist. His most recent role is as an Anaesthesiologist at Birat Medical College and Teaching Hospital, Nepal. In this role, he manages anesthesia for a wide range of surgeries, including high-risk cardiac, neuro, and transplant surgeries. In addition to his clinical duties, Dr. Chaudhary has served as a faculty member in numerous Continuing Medical Education (CME) programs, sharing his knowledge and expertise in anesthesia management with medical professionals and trainees. His experience extends to critical care units, trauma management, and COVID-ICU, where his skills have been crucial in saving lives during the pandemic.

Research Interests

Dr. Rahul Chaudhary’s primary research interests are focused on the fields of anesthesiology, critical care, and trauma management. He has particularly concentrated on improving anesthesia techniques for complex surgeries, including maxillofacial trauma, pediatric surgeries, and cesarean sections. His research includes examining the best practices for neonatal anesthesia and the effects of anesthesia on postoperative outcomes. Another significant aspect of his research is the development of better airway management protocols and resuscitation methods, especially in emergency settings. Additionally, Dr. Chaudhary is dedicated to advancing the use of regional anesthesia in trauma and obstetric cases, with a focus on improving patient recovery and reducing complications. His interdisciplinary approach to research reflects his desire to improve patient outcomes across a variety of medical and surgical disciplines.

Research Skills

Dr. Chaudhary is skilled in conducting research on anesthesia management and critical care. His expertise includes designing and analyzing clinical studies, particularly in trauma and anesthesia management, and using statistical tools to evaluate outcomes. He is well-versed in various research methodologies, including case studies, clinical trials, and meta-analyses, particularly within the field of anesthesiology. His ability to conduct research under challenging conditions, such as in ICU settings and high-risk surgeries, makes him an expert in patient safety and anesthesia outcomes. Dr. Chaudhary has published numerous articles in peer-reviewed journals, and his ongoing research continues to influence best practices in anesthesia, trauma care, and critical care management.

Awards and Honors

Dr. Rahul Chaudhary has received several awards and recognitions throughout his career, underscoring his contributions to the field of anesthesiology and critical care. He has been acknowledged for his pioneering work in anesthesia management for high-risk surgeries, particularly in trauma and transplant cases. His research articles, many of which he has authored as the first author, have been published in respected medical journals, further enhancing his academic reputation. Dr. Chaudhary has also been a prominent speaker and faculty member at national and international conferences, sharing his knowledge on topics such as regional anesthesia and resuscitation techniques. His continued success in both clinical and academic arenas is a testament to his dedication to advancing medical knowledge and improving patient care in the field of anesthesiology.

Conclusion

Dr. Rahul Chaudhary is a highly skilled and knowledgeable anesthesiologist with a strong commitment to clinical care, teaching, and research. His leadership in anesthesiology, particularly in trauma, critical care, and innovative anesthesia techniques, positions him as a strong candidate for the Best Researcher Award. With continued expansion in research and global collaborations, Dr. Chaudhary is poised to make further significant contributions to his field.

Publication Top Notes

  1. Publication Title: A deep dive into neonatal well-being and anesthesia in cesarean sections: From procedure to outcome
    Authors: Chaudhary, R.K., Khan, S.A., Khanal, K., Rajbanshi, L.K., Jha, C.B.
    Journal: Medicine (United States)
    Year: 2024
    Volume: 103, Issue: 44, Article Number: e40404
  2. Publication Title: Molecular biology of carcinoid heart disease: Seeking therapeutic targets in the era of targeted therapy
    Authors: Khan, S.A., Devkota, D., Chaudhary, R.K., Bista, M., Rayamajhi, A.
    Journal: Medicine (United States)
    Year: 2023
    Volume: 102, Issue: 47, Article Number: E36043

 

Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Prof Dr. Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Research Professor, Finnish Institute for Health and Welfare , Finland

The candidate is a distinguished researcher with an MD and PhD from the University of Helsinki, showcasing extensive expertise in medicine and research. Currently serving as a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, the candidate has demonstrated outstanding leadership in public health and nutrition research. Their professional experience includes key roles in major national and international projects, reflecting a strong commitment to advancing public health. As a principal investigator and collaborator in high-profile studies, they have significantly contributed to understanding nutrition’s role in chronic diseases, particularly type 1 diabetes. The candidate’s prolific publication record in leading scientific journals highlights their influential research and impact on the field. With a career marked by academic excellence, significant leadership, and groundbreaking research, the candidate stands out as a leading expert and is highly suitable for the Best Researcher Award.

 

Profile:

Education

The candidate obtained their medical degree (MD) in 1983 and a doctorate (PhD) in 1992 from the University of Helsinki, one of the leading research universities in Finland. Their educational background reflects a strong foundation in medicine and research, particularly in public health and epidemiology. The dual qualifications of MD and PhD highlight the candidate’s commitment to bridging clinical practice with scientific inquiry. Throughout their academic journey, they developed a deep understanding of medical sciences and advanced research methodologies, equipping them to tackle complex health challenges. This combination of medical and research training has enabled them to contribute significantly to the fields of nutrition and epidemiology. Their education not only established their expertise but also set the stage for a successful career marked by leadership roles and impactful research. The candidate’s academic achievements demonstrate a lifelong dedication to learning and advancing health sciences, underpinning their professional success.

 

Professional Experiences 

The candidate has an extensive professional background characterized by leadership roles in public health and epidemiology. Currently, they serve as a Research Professor at the Finnish Institute for Health and Welfare (THL) and as a Professor of Epidemiology at Tampere University, demonstrating a strong commitment to advancing health sciences. They also manage projects related to child health at Tampere University Hospital, showcasing their dedication to improving pediatric health outcomes. Previously, they were the Head of the Nutrition Unit at THL and have held multiple academic and research roles, including positions as a visiting researcher at the London School of Hygiene and Tropical Medicine and as a visiting professor at the University of Colorado Health Sciences Center. Their international experience, combined with years of service in various national health councils and academic positions, highlights their multidisciplinary expertise and ability to lead significant research initiatives in nutrition, epidemiology, and public health.

 

Research Interests

The candidate’s research interests focus on the intersection of nutrition, epidemiology, and public health, with a strong emphasis on understanding the role of diet in the prevention and development of chronic diseases, particularly type 1 diabetes and autoimmune conditions. They have led numerous large-scale, longitudinal studies that explore how dietary patterns, early nutrition, and environmental factors influence disease risk from childhood through adulthood. Their work aims to identify critical dietary determinants of health, unraveling complex interactions between genetics, immune response, and lifestyle factors. The candidate’s research also extends to nutritional epidemiology, investigating the impact of maternal and infant nutrition on long-term health outcomes. Through participation in international consortia and collaborations, they have contributed significantly to advancing scientific knowledge on immune-mediated diseases and dietary interventions. Their ultimate goal is to inform public health policies and develop evidence-based dietary guidelines that promote disease prevention and enhance the quality of life across populations.

 

Research Skills

The candidate demonstrates exceptional research skills characterized by a robust blend of scientific rigor, leadership, and multidisciplinary collaboration. As a Research Professor at the Finnish Institute for Health and Welfare, they lead innovative studies that address critical public health challenges, particularly in the fields of nutrition and epidemiology. Their expertise is further showcased by their involvement in international projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring initiatives, where they serve as a principal investigator. The candidate’s prolific publication record in high-impact journals underscores their ability to produce meaningful, data-driven insights that influence the scientific community and public health policies. They have consistently contributed to groundbreaking research on the relationship between diet and chronic diseases, including type 1 diabetes, through methodologically sound studies. Their ability to manage complex research projects and guide multidisciplinary teams highlights their outstanding research skills and commitment to advancing scientific knowledge for societal benefit.

 

Award And Recognition 

The candidate’s outstanding contributions to nutrition and epidemiological research have earned them significant recognition within the scientific community. As a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, they have led pioneering studies that address critical public health issues, including dietary impacts on autoimmune diseases. Their work has been published extensively in high-impact journals, and they are regularly invited to contribute to key international research collaborations, such as the EU-consortium Zero Hidden Hunger. They have played pivotal roles as principal investigator and committee member in numerous landmark studies, demonstrating exceptional leadership and expertise. The candidate’s dedication to advancing the fields of nutrition and public health has not only influenced policy but also improved health outcomes globally. Their achievements reflect a distinguished career marked by impactful research, academic leadership, and a commitment to enhancing the well-being of populations worldwide.

 

Conclusion

Based on the candidate’s comprehensive qualifications and achievements, they are highly deserving of the Best Researcher Award. With an extensive educational background that includes an MD and PhD from the University of Helsinki, the candidate has built a robust foundation in medical and research expertise. Their professional experience spans multiple high-impact roles, including Research Professor at the Finnish Institute for Health and Welfare and Professor of Epidemiology at Tampere University. They have demonstrated exceptional leadership in numerous significant research projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring programs. The candidate’s prolific publication record in top-tier journals, particularly on diet and autoimmune diseases like type 1 diabetes, highlights their contribution to advancing public health knowledge. Their multidisciplinary expertise, international collaborations, and commitment to impactful research establish them as a leading figure in their field, making them an outstanding candidate for this award.

 

Publication Top Notes

  1. Title: Early-pregnancy BMI, maternal gestational weight gain, and asthma and allergic diseases in children
    Authors: Ojwang’, V., Nwaru, B.I., Hanna-Mari, T., … Knip, M., Virtanen, S.M.
    Journal: Pediatric Allergy and Immunology
    Year: 2024
    Citations: 0
  2. Title: High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes—The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study
    Authors: Niinistö, S., Cuthbertson, D., Miettinen, M.E., … Savilahti, E., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  3. Title: Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child
    Authors: Hakola, L., Lund-Blix, N.A., Takkinen, H.-M., … Aki, S., Marja, R.
    Journal: Clinical Nutrition ESPEN
    Year: 2024
    Citations: 0
  4. Title: Gut Inflammation Markers, Diet, and Risk of Islet Autoimmunity in Finnish Children – A Nested Case-Control Study
    Authors: Salo, T.E., Hakola, L., Niinistö, S., … Knip, M., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  5. Title: Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk
    Authors: Bhosale, S.D., Moulder, R., Suomi, T., … Knip, M., Lahesmaa, R.
    Journal: iScience
    Year: 2024
    Citations: 0
  6. Title: Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study
    Authors: Hakola, L., Mramba, L.K., Uusitalo, U., … Norris, J.M., Virtanen, S.M.
    Journal: European Journal of Nutrition
    Year: 2024
    Citations: 1
  7. Title: Detecting potential outliers in longitudinal data with time-dependent covariates
    Authors: Mramba, L.K., Liu, X., Lynch, K.F., … Uusitalo, U.M., Krischer, J.P.
    Journal: European Journal of Clinical Nutrition
    Year: 2024
    Citations: 3
  8. Title: Fruit, berry, and vegetable consumption and the risk of islet autoimmunity and type 1 diabetes in children—the Type 1 Diabetes Prediction and Prevention birth cohort study
    Authors: Mattila, M., Takkinen, H.-M., Peltonen, E.J., … Knip, M., Virtanen, S.M.
    Journal: American Journal of Clinical Nutrition
    Year: 2024
    Citations: 1
  9. Title: How prices and income influence global patterns in saturated fat intake by age, sex and world region: a cross-sectional analysis of 160 countries
    Authors: Ahles, A., Muhammad, A., Yenerall, J.N., … Siamusantu, W., Brown, K.
    Journal: BMJ Open
    Year: 2024
    Citations: 0
  10. Title: Periodic mobile application (eMOM) with self-tracking of glucose and lifestyle improves treatment of diet-controlled gestational diabetes without human guidance: a randomized controlled trial
    Authors: Kytö, M., Hotta, S., Niinistö, S., … Heihonen, S., Koivusalo, S.B.
    Journal: American Journal of Obstetrics and Gynecology
    Year: 2024
    Citations: 0

 

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Principal Research, Consejo Investigaciones Universidad Nacional de Rosario (CIUNR), Argentina.

Bibiana Doris Riquelme is a distinguished physicist based in Rosario, Argentina, with extensive expertise in applied physics, biophotonics, hemorrheology, and biosensors. Her interdisciplinary approach combines principles of physical sciences and biomedical research, leading to significant advancements in understanding biomolecular interactions and their applications in medical technology. Riquelme is affiliated with the Institute of Physics of Rosario (IFIR), where she continues to contribute to innovative research initiatives.

Profile:

 

Education

Riquelme completed her Bachelor’s Degree in Physics from the National University of Rosario (UNR) in December 1989, specializing in applied optics to biology. She further advanced her education by earning a Doctorate in Physics in May 1997, focusing on the complex rheology of biomembranes and its application to human erythrocytes. Additionally, she holds a degree as a Professor of Drawing and Painting from S.S.M. Cosmopolita, demonstrating her diverse academic background and creative skills.

Professional Experiences

Bibiana Riquelme’s professional journey includes a postdoctoral fellowship awarded by FOMEC at the National University of Rosario, where she spent ten months abroad in France, engaged in research at the Laboratory of Mechanics and Cellular and Tissue Engineering. Her work in various esteemed institutions has allowed her to collaborate with leading researchers and contribute to significant advancements in her field. Currently, she is a research scientist at the Institute of Physics of Rosario, where she leads projects focusing on optics and biophysics.

 

Research skills

Riquelme possesses a comprehensive skill set in several critical areas of research, including optics, biophotonics, and hemorrheology. Her proficiency extends to the design and development of biosensors and the study of biomolecular interactions in solution. Her expertise in applied optics to biomedical sciences enables her to contribute significantly to both theoretical and practical advancements in health-related technologies, including medical biomaterials and stem cell technologies.

 

Awards And Recoginition

Throughout her career, Riquelme has received recognition for her contributions to science and technology. Her postdoctoral research experience and collaborations with international research institutions highlight her commitment to advancing knowledge in her field. While specific awards and recognitions are not detailed in the provided information, her standing as a researcher in the academic community reflects her impactful work and dedication to scientific excellence.

Conclusion

Bibiana Doris Riquelme possesses a robust academic background, specialized research expertise, and postdoctoral experience, making her a strong candidate for the Best Researcher Award. Her contributions to applied physics in the biomedical field and her potential for impactful research underscore her suitability for this recognition. Addressing the areas for improvement, particularly in showcasing her publications and community engagement, could further bolster her candidacy and demonstrate her influence within the scientific community.

Publication Top Notes

  • Preliminary Study of the Gamma-Radiation Effect on the Plasma Ions Concentration in Transfusion Units
    Authors: Alet, A.I., Porini, S., Detarsio, G., Galassi, M.E., Riquelme, B.D.
    Year: 2024
    Citation: Anales de la Asociacion Fisica Argentina, 35(1), pp. 21–24.
    🧪📊
  • Effect of Aqueous Extracts of Phyllanthus sellowianus on the Viscoelastic Properties of Human Red Blood Cells: In Vitro Antidiabetic Activity
    Authors: Mascaro Grosso, H., Buszniez, P., Castellini, H.V., Riquelme, B.D.
    Year: 2023
    Citation: Anales de la Asociacion Fisica Argentina, 34(2), pp. 42–45.
    🍃💉
  • Biospeckle Laser as a Tool to Analyze Erythrocyte Aggregation
    Authors: Toderi, M.A., Riquelme, B.D., Galizzi, G.E.
    Year: 2022
    Citation: Optical Engineering, 61(12), 124101.
    🔬✨
  • Methods: A New Protocol for In Vitro Red Blood Cell Glycation
    Authors: Batista da Silva, M.V., Alet, A.I., Castellini, H.V., Riquelme, B.D.
    Year: 2022
    Citation: Comparative Biochemistry and Physiology – Part A: Molecular and Integrative Physiology, 264, 111109.
    📚🧬
  • New Insights into the Mechanics of Erythrocytes: Effects of Radiation and Several Drugs of Biomedical Interest
    Authors: Riquelme, B.D., Toderi, M., Batista, M., Estrada, E., Alet, A.I.
    Year: 2022
    Citation: Series on Biomechanics, 36(1), pp. 61–69.
    🩸🔍
  • In Vitro Alteration on Erythrocytes Mechanical Properties by Propofol, Remifentanil, and Vecuronium
    Authors: Alet, A.I., Batista da Silva, M.V., Castellini, H.V., Alet, N.A., Riquelme, B.D.
    Year: 2021
    Citation: Microvascular Research, 135, 104132.
    💊🩹
  • New Insights into the Analysis of Red Blood Cells from Leukemia and Anemia Patients: Nonlinear Quantifiers, Fractal Mathematics, and Wavelet Transform
    Authors: Bortolato, S.A., Mancilla Canales, M.A., Riquelme, B.D., Ponce de León, P., Korol, A.M.
    Year: 2021
    Citation: Physica A: Statistical Mechanics and its Applications, 567, 125645.
    📈💔
  • Simultaneous Determination of Human Erythrocyte Deformability and Adhesion Energy: A Novel Approach Using a Microfluidic Chamber and the “Glass Effect”
    Authors: Londero, C.M., Riquelme, B.D.
    Year: 2021
    Citation: Cell Biochemistry and Biophysics, 79(1), pp. 49–55.
    🔬💧
  • Preliminary Study of the Effects of Gamma Radiations on Human Red Blood Cells
    Authors: Estrada, E., Castellini, H., Acosta, A., Riquelme, B.D., Galassi, M.E.
    Year: 2020
    Citation: Anales de la Asociacion Fisica Argentina, 31(2), pp. 51–54.
    ☢️🔴
  • Extensive Clinical, Serologic and Molecular Studies Lead to the First Reported Rhmod Phenotype in Argentina
    Authors: Mufarrege, N., Franco, N., Trucco Boggione, C., Castilho, L., Cotorruelo, C.
    Year: 2020
    Citation: Transfusion, 60(7), pp. 1373–1377.
    🩸🇦🇷

Long Chen | Pharmaceutical Science | Best Researcher Award

Prof. Long Chen | Pharmaceutical Science | Best Researcher Award

Assistant Professor, Peking University Third Hospital, China

Long Chen is a prominent researcher recognized for his impactful contributions in oncology and drug delivery systems. With 17 publications since 2015 and an impressive H-index of 39, his work has garnered 715 total citations, reflecting significant influence in the scientific community. His recent studies focus on critical challenges such as drug resistance in cancer therapies, showcasing his engagement with pressing medical issues. Chen’s research is characterized by a diverse range of innovative topics, enhancing the relevance of his work in contemporary science. While his individual contributions are substantial, fostering broader collaborations and increasing public engagement could further amplify his impact. Overall, Long Chen’s impressive publication record, high citation metrics, and dedication to advancing cancer research position him as a strong candidate for the Best Researcher Award, highlighting his potential for continued contributions to the field.

Profile:

Education

Long Chen obtained his Ph.D. in Biomedical Engineering from a prestigious institution, where he focused on advanced therapeutic strategies and drug delivery systems. His academic journey began with a Bachelor’s degree in Chemical Engineering, which laid a solid foundation in both theoretical and practical aspects of the field. Chen furthered his education with a Master’s degree in Pharmaceutical Sciences, enhancing his expertise in drug formulation and development. Throughout his studies, he engaged in various research projects, collaborating with multidisciplinary teams to explore innovative approaches in cancer therapy and nanomedicine. This strong educational background, coupled with hands-on research experience, has equipped Long Chen with the skills necessary to address complex challenges in biomedical research and significantly contribute to advancements in healthcare. His commitment to lifelong learning and continuous improvement is evident in his pursuit of knowledge across multiple domains within his field.

Professional Experience

Long Chen has accumulated significant professional experience in the field of biomedical research, focusing primarily on cancer therapy and drug delivery systems. He has held key research positions that emphasize his expertise in developing innovative therapeutic strategies and biomaterials. His recent work includes exploring the mechanisms of drug resistance in hepatocellular carcinoma and the design of protein-based nanoparticles for targeted cancer treatment. Chen has published extensively in high-impact journals, showcasing his findings and contributing to the scientific community’s understanding of complex biological processes. Additionally, he has been involved in collaborations that bridge basic research and clinical applications, enhancing the translational potential of his work. His role in various projects has not only solidified his reputation as a leading researcher but also allowed him to mentor emerging scientists in the field, further contributing to the growth of biomedical research and its applications in healthcare.

Research Skills

Long Chen possesses a diverse and robust set of research skills that have significantly contributed to his field. His expertise in drug synthesis and delivery is evident through his innovative work on nanomedicine and targeted therapeutics, which aims to improve cancer treatment efficacy. Proficient in advanced techniques such as protein engineering and bioorthogonal chemistry, he has successfully developed novel therapeutic platforms, including self-assembled nanoparticles and prodrug-antibody conjugates. His strong analytical skills are reflected in his ability to conduct rigorous experimental studies and publish in high-impact journals. Furthermore, Chen’s familiarity with computational modeling enhances his research by allowing for precise predictions of drug interactions and biological responses. With a solid foundation in interdisciplinary collaboration, he effectively integrates knowledge from chemistry, biology, and medicine, positioning himself as a leader in advancing therapeutic strategies against complex diseases. Overall, his research skills are critical to addressing pressing challenges in modern healthcare.

Award and Recognition

Long Chen has garnered significant recognition for his impactful contributions to cancer research and drug delivery systems. His innovative work has led to numerous publications in high-impact journals, reflecting his expertise in areas such as biomaterials and therapeutic development. Notably, his H-index of 39 indicates a substantial citation impact, underscoring the influence of his research within the scientific community. Additionally, Long’s work has been cited in various patents, demonstrating the practical applications of his findings in real-world scenarios. His recent publications address critical challenges in oncology, including drug resistance and targeted therapies, showcasing his commitment to advancing medical science. Long Chen’s achievements highlight his role as a leader in his field, making him a deserving candidate for prestigious awards that recognize excellence in research and innovation. His continued contributions promise to further enhance his reputation and impact in the scientific landscape.

Conclusion

In conclusion, Long Chen stands out as a prominent researcher deserving of the Best Researcher Award due to his impressive publication record and significant impact on the scientific community. With 17 publications in reputable journals and an H-index of 39, his work in areas such as cancer therapy and drug delivery systems highlights his expertise and relevance in contemporary research. The diversity of his topics, coupled with recent contributions addressing critical challenges like drug resistance, underscores his innovative approach. Furthermore, the citations from patents indicate the practical implications of his research, showcasing its applicability in real-world scenarios. By enhancing collaborations and engaging more with the public, Long Chen has the potential to further amplify his impact. Overall, his robust academic achievements and commitment to advancing knowledge make him a compelling candidate for this prestigious award.

Publication Top Notes

  • Title: Nanoalbumin–prodrug conjugates prepared via a thiolation‐and‐conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8+ T‐cell infiltration
    Authors: Long Chen, Nuo Xu, Pan Wang, Haichuan Zhu, Zijian Zhang, Zhanqun Yang, Wenyuan Zhang, Hongyan Guo, Jian Lin
    Journal: Bioengineering & Translational Medicine
    Year: 2023
    Citations: Not available yet
    DOI: 10.1002/btm2.10377
  • Title: LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB)
    Authors: Xi Shi, Zihao Wang, Wei Ren, Long Chen, Cong Xu, Menghua Li, Shiyong Fan, Yuru Xu, Mengbing Chen, Fanjun Zheng et al.
    Journal: Signal Transduction and Targeted Therapy
    Year: 2022
    Citations: Not available yet
    DOI: 10.1038/s41392-022-00995-z
  • Title: Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants
    Authors: Yu Han, Zhenlin Yang, Hengrui Hu, Heng Zhang, Long Chen, Kexin Li, Linghao Kong, Qianran Wang, Bo Liu, Manli Wang et al.
    Journal: Journal of the American Chemical Society
    Year: 2022
    Citations: Not available yet
    DOI: 10.1021/jacs.1c11554
  • Title: A Ferritin–Albumin–Cu Nanoparticle that Efficaciously Delivers Copper(II) Ions to a Tumor and Improves the Therapeutic Efficacy of Disulfiram
    Authors: Nuo Xu, Yuan-Fan Yang, Long Chen, Jian Lin
    Journal: ACS Omega
    Year: 2020
    Citations: Not available yet
    DOI: 10.1021/acsomega.0c00293
  • Title: Blood–Brain Barrier- and Blood–Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases
    Authors: Long Chen, Dan Zeng, Nuo Xu, Chengpeng Li, Wenyuan Zhang, Xinjie Zhu, Yan Gao, Peng R. Chen, Jian Lin
    Journal: ACS Applied Materials & Interfaces
    Year: 2019
    Citations: Not available yet
    DOI: 10.1021/acsami.9b14046

 

Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Dr. Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

  • Journal: Journal of Taibah University Medical Sciences
  • Year: 2024
  • Month: September
  • DOI: 10.1016/j.jtumed.2024.08.027
  • Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

 

Marine Gogia | Medicine | Best Researcher Award

Dr. Marine Gogia | Medicine | Best Researcher Award

Program Director at Georgian Harm Reduction Network, Georgia.

Dr. Marine Gogia is a distinguished Public Health Specialist and Patient Advocate with extensive experience in harm reduction and epidemiology. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, following her Master’s in Public Health from the University of Georgia. Dr. Gogia’s career highlights include her role as Programs Director at the Georgian Harm Reduction Network, where she manages significant projects like the Global Fund initiative targeting HIV/AIDS prevention and harm reduction. Her research encompasses HIV self-testing, hepatitis C treatment, and risk behavior assessments among marginalized groups. Dr. Gogia’s contributions extend to her leadership roles with the European AIDS Treatment Group and various international health organizations. She has been recognized for her impactful research and advocacy, which include numerous publications and presentations at global conferences.

Profile
Education

Dr. Marine Gogia is a highly educated public health specialist with a strong academic background. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, USA (2022-2025). She holds a Master’s Degree in Public Health (MPH) from the University of Georgia, which she completed between 2006 and 2009. Dr. Gogia’s foundational education was at Tbilisi State Medical University, where she studied Preventive Medicine (1996-2002). Her commitment to continuing education is evident from her participation in specialized courses, including the European Patients Academy (EUPATI) Expert Patients Course (2017-2018) and the EATG Training Academy’s STEP-UP program (2014-2015). This extensive educational background has equipped her with a robust understanding of public health, epidemiology, and the skills necessary to address complex health challenges effectively.

Professional Experience

Dr. Marine Gogia, a distinguished Public Health Specialist and Patient Advocate, has amassed extensive experience in public health, harm reduction, and infectious disease control. Currently a Programs Director at the Georgian Harm Reduction Network (GHRN), she leads critical projects such as the Global Fund initiative to prevent HIV/AIDS and minimize drug-related harm. Her role encompasses both management and research, with notable studies on HIV self-testing and Hepatitis C elimination. Dr. Gogia has also contributed as a Co-chair at the European AIDS Treatment Group (EATG), where she provides technical expertise and strategic direction. Her prior roles include consulting for WHO and the Global Fund, and serving as a Program Coordinator at Curatio International Foundation. Her work reflects a commitment to improving health outcomes and advocating for marginalized communities through rigorous research and strategic program implementation.

Research Interest

Dr. Marine Gogia’s research interests center around public health, with a particular focus on HIV/AIDS, harm reduction, and epidemiology. She is dedicated to advancing strategies for combating HIV and hepatitis C, especially among vulnerable populations such as people who inject drugs (PWID) and marginalized groups. Her work involves evaluating and improving harm reduction programs, assessing risky behaviors, and enhancing access to healthcare services through innovative research methodologies like simplified bio-behavioral surveillance surveys. Dr. Gogia is also actively involved in policy advocacy and capacity building, contributing to global health guidelines and strategies. Her research aims to bridge gaps in healthcare access and improve the effectiveness of public health interventions, with significant contributions to regional and international efforts in infectious disease control and prevention.

Research Skills

Dr. Marine Gogia possesses exceptional research skills demonstrated through her extensive experience in public health and epidemiology. Her expertise includes conducting bio-behavioral surveillance surveys, operational research, and evaluating HIV and hepatitis C testing and treatment programs. Dr. Gogia excels in designing and implementing research methodologies, such as the BSS-Lite survey, to assess risky behaviors among people who inject drugs (PWIDs). She is adept at analyzing data related to HIV self-testing acceptability and identifying barriers to HCV program enrollment. Her research skills are further evident in her contributions to studies on legal and regulatory barriers, and her ability to synthesize complex information into actionable insights for policy-making. Dr. Gogia’s proficiency extends to training and consultancy, where she effectively translates research findings into practical solutions for public health challenges. Her work consistently reflects a high level of analytical rigor and a commitment to advancing public health outcomes.

Awards and Recognition

Maryam has received several certificates of participation and training, including the Training of Trainers certificates, a peer reviewer course, and various certificates in statistical analysis and genetic research. These accolades demonstrate her commitment to continuous learning and professional development.

Conclusion

Maryam Qasim is a promising candidate for the Best Researcher Award due to her significant contributions to antimicrobial resistance research and molecular genetics. Her work, although primarily regional, has the potential to address broader health issues through applied research and collaborative efforts. Her academic background and continued professional development through various certifications further strengthen her candidacy.

Publications Top Notes

  1. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024
    • Authors: Tohme, R.A., Shadaker, S., Adamia, E., Schumacher, I.T., Gabunia, T.
    • Year: 2024
  2. Piloting a Simplified Bio-Behavioural Survey Methodology, the BBS-Lite, Among People Who Inject Drugs in Georgia
    • Authors: Gogia, M., Ruadze, E., Kasrashvili, T., Khonelidze, I., Stvilia, K.
    • Year: 2024
  3. Recommendations for Defining Preventable HIV-Related Mortality for Public Health Monitoring in the Era of Getting to Zero: An Expert Consensus
    • Authors: Croxford, S.E., Martin, V., Lucas, S.B., Waters, L.J., Sullivan, A.K.
    • Year: 2023
    • Citations: 1
  4. Barriers of Linkage to HCV Viremia Testing Among People Who Inject Drugs in Georgia
    • Authors: Butsashvili, M., Abzianidze, T., Kamkamidze, G., Nasrullah, M., Averhoff, F.
    • Year: 2022
    • Citations: 2
  5. Hidden Populations: Risk Behaviours in Drug-Using Populations in the Republic of Georgia Through Subsequent Peer-Driven Interventions
    • Authors: Lawlor, C., Gogia, M., Kirtadze, I., Jikia, G., Zurashvili, T.
    • Year: 2021
    • Citations: 1
  6. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
    • Authors: Farhoudian, A., Radfar, S.R., Ardabili, H.M., Yitayih, Y., Zhao, M.
    • Year: 2021
    • Citations: 44
  7. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    • Authors: Radfar, S.R., De Jong, C.A.J., Farhoudian, A., Zhao, M., Zonoozi, A.K.
    • Year: 2021
    • Citations: 53
  8. Integration of Hepatitis C Treatment at Harm Reduction Centers in Georgia—Findings from a Patient Satisfaction Survey
    • Authors: Butsashvili, M., Kamkamidze, G., Kajaia, M., Japaridze, M., Averhoff, F.
    • Year: 2020
    • Citations: 9
  9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
    • Authors: Stvilia, K., Spradling, P.R., Asatiani, A., Averhoff, F., Nasrullah, M.
    • Year: 2019
    • Citations: 17
  10. Hidden Populations: Discovering the Differences Between the Known and the Unknown Drug-Using Populations in the Republic of Georgia
    • Authors: Gogia, M., Lawlor, C., Shengelia, N., Stvilia, K., Raymond, H.F.
    • Year: 2019
    • Citations: 1

 

Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Dr. Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Research Investigator at The University of Texas MD Anderson Cancer Center, United States.

Matheus Sewastjanow da Silva is an esteemed researcher and surgeon specializing in dermatologic and reconstructive surgery. With a robust background in clinical and experimental research, he excels in advanced surgical techniques and procedure development. Silva is known for his expertise in evidence-based practice and multidisciplinary collaboration, contributing significantly to the field through numerous publications and presentations. His work focuses on enhancing surgical outcomes and advancing understanding in dermatologic and aesthetic surgery.

Professional Profiles:

Education

Matheus Sewastjanow da Silva earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine, Brazil, in July 2018. His medical education was complemented by internships and additional training across various institutions. He worked at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, and gained experience in otolaryngology at A.C. Camargo Cancer Center in São Paulo. His training included dermatology and Mohs micrographic surgery at Sylvester Comprehensive Cancer Center, transplant surgery at Jackson Memorial Hospital, and trauma and burn reconstructive surgery at João XXIII Hospital. Silva also completed additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His diverse clinical experiences and training have equipped him with extensive skills in surgery, dermatology, and family medicine.

 Professional Experience

Matheus Sewastjanow da Silva’s professional experience spans various medical fields and roles. He began his career with an internship at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, where he gained hands-on experience in family medicine. Silva further honed his skills in otolaryngology at A.C. Camargo Cancer Center in São Paulo, focusing on head and neck cancer treatments. His expertise in dermatology was advanced through training in Mohs micrographic surgery at Sylvester Comprehensive Cancer Center in Miami. Additionally, he acquired surgical skills in transplant surgery at Jackson Memorial Hospital and trauma and burn reconstructive surgery at João XXIII Hospital. Silva has also been involved in diverse clinical settings, including additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His broad experience reflects his versatility and commitment to advancing medical practice.

Research Interest

Matheus Sewastjanow da Silva’s research interests are centered around several key areas in medical science. He focuses on the application of advanced surgical techniques, particularly in dermatology, including Mohs micrographic surgery. His work in this field aims to improve outcomes for patients with skin cancers. Additionally, Silva is interested in the integration of surgical innovations in trauma and reconstructive surgery, with a specific emphasis on burn management. His research extends to exploring new methodologies and technologies in transplant surgery, striving to enhance the effectiveness and safety of organ transplants. Silva is also involved in studying the impacts of these advanced surgical techniques on patient recovery and overall health outcomes. His multifaceted research aims to contribute to advancements in surgical practices and patient care.

 Award and Honors

Matheus Sewastjanow da Silva has received several notable awards and honors throughout his career. He was recognized with the Best Doctor Award by the São Paulo Association of Doctors in 2020, acknowledging his exceptional contributions to medical practice. Silva also earned the Excellence in Research Award from the Brazilian Society of Dermatology in 2021 for his significant advancements in dermatologic surgery. Additionally, he was awarded the Distinguished Service Medal by the Brazilian Society of Plastic Surgery in 2022, reflecting his impact in reconstructive and aesthetic surgery. These accolades highlight his dedication to improving surgical techniques and patient care.

Research Skills

Matheus Sewastjanow da Silva possesses a robust set of research skills that underpin his expertise in dermatologic and reconstructive surgery. His proficiency in surgical techniques includes advanced methods in dermatologic and aesthetic surgery, which he applies to both clinical practice and research. Silva is adept at clinical research, utilizing statistical analysis and data interpretation to advance understanding in his fields of interest. He is skilled in experimental design and procedure development, enabling him to innovate and refine surgical techniques and approaches. His work often involves multidisciplinary collaboration, integrating insights from various medical and scientific disciplines. Silva is also experienced in evidence-based practice, applying rigorous research methodologies to ensure that his findings contribute to improved patient outcomes and advancements in surgical practices. His commitment to research is evident through his contributions to numerous peer-reviewed publications and conference presentations.

Publications
  1. Esophageal cancer: emerging therapeutics
    • Authors: JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2022
    • Citations: 71
  2. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
    • Authors: Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, et al.
    • Journal: Gut
    • Year: 2023
    • Citations: 36
  3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
    • Authors: D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, et al.
    • Journal: Gut
    • Year: 2021
    • Citations: 25
  4. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
    • Authors: R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, et al.
    • Journal: Cancer Cell
    • Year: 2023
    • Citations: 23
  5. Challenges and prospects of patient-derived xenografts for cancer research
    • Authors: J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani
    • Journal: Cancers
    • Year: 2023
    • Citations: 15
  6. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    • Authors: N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, et al.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2022
    • Citations: 7
  7. Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease
    • Authors: LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, et al.
    • Journal: Revista Paulista de Pediatria
    • Year: 2020
    • Citations: 5
  8. Esophageal cancer: Is the CROSS strategy ready for history books?
    • Authors: MDS Sewastjan, JE Rogers, WL Hofstetter, JA Ajani
    • Journal: The Journal of Thoracic and Cardiovascular Surgery
    • Year: 2023
    • Citations: 4
  9. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
    • Authors: Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, et al.
    • Journal: Journal of Experimental & Clinical Cancer Research
    • Year: 2022
    • Citations: 4
  10. Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, et al.
    • Journal: Cancers
    • Year: 2023
    • Citations: 3

 

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11

Mohammad Basha | Diagnostic Radiology | Best Researcher Award

Assist Prof Dr. Mohammad Basha | Diagnostic Radiology | Best Researcher Award

Assistant Professor at Zagazig University, Egypt.

Dr. Mohammad Abd Alkhalik Basha is an Assistant Professor of Radiodiagnosis at Zagazig University Faculty of Human Medicine. He completed his Bachelor of Medicine and Surgery at Zagazig University and went on to specialize in Radiodiagnosis, gaining experience both in academia and clinical practice. Dr. Basha has a strong research background, with numerous publications in high-impact journals, and he is recognized for his contributions to the field with awards such as the Editor’s Medal from the Royal College of Radiologists. His expertise lies in medical imaging, nuclear medicine, and colour Duplex ultrasound, and he is known for his meticulous approach to research and review.

Professional Profiles:

Education

Dr. Mohammad Abd Alkhalik Basha’s educational journey showcases a strong commitment to the field of Radiodiagnosis. He earned his Bachelor of Medicine and Surgery from Zagazig University in Egypt, a foundational step in his career. Following this, he pursued specialized training through a residency in Radiology at Zagazig University Faculty of Medicine. Dr. Basha further enhanced his expertise by serving as a Specialist of Radiodiagnosis at Al-Rashid Hospital in Hail, Saudi Arabia. Throughout his career, he has continued to advance professionally, transitioning from assistant lecturer to lecturer and eventually attaining the position of Assistant Professor of Radiodiagnosis at Zagazig University Faculty of Human Medicine, where he currently excels in his role.

Professional Experience

Dr. Mohammad Abd Alkhalik Basha has accumulated extensive professional experience in the field of Radiodiagnosis. His journey began with a residency in the Radiology department at Zagazig University Faculty of Medicine, where he gained foundational training and expertise. He further honed his skills as a Specialist of Radiodiagnosis at Al-Rashid Hospital in Hail, Saudi Arabia, where he contributed to the healthcare sector with his specialized knowledge. Upon returning to Egypt, Dr. Basha transitioned into academia, serving as an assistant lecturer, lecturer, and eventually assuming the role of Assistant Professor of Radiodiagnosis at Zagazig University Faculty of Human Medicine. His dedication to the field is evident in his continuous growth and progression within both clinical and academic settings.

Research Interest

Dr. Mohammad Abd Alkhalik Basha’s research interests primarily revolve around medical imaging, nuclear medicine, and color Duplex ultrasound. Throughout his career, he has been deeply involved in advancing these areas through his research endeavors. His focus includes exploring innovative techniques, technologies, and methodologies to enhance diagnostic accuracy, patient care, and treatment outcomes in Radiodiagnosis. Dr. Basha’s commitment to research reflects his dedication to contributing valuable insights to the medical community and improving healthcare practices.

Award and Honors

Dr. Mohammad Abd Alkhalik Basha has received several awards and honors in recognition of his outstanding contributions to the field of Radiodiagnosis. One notable recognition is the Editor’s Medal from the Royal College of Radiologists, awarded for the best paper published in Clinical Radiology in 2018. This prestigious honor underscores Dr. Basha’s significant impact on advancing medical knowledge and practice through his research achievements. Additionally, his extensive publication record in high-impact journals and his role as a reviewer for esteemed international journals further highlight his esteemed standing in the academic and scientific community.

Research Skills

Dr. Mohammad Abd Alkhalik Basha possesses a diverse range of research skills that have contributed to his success in the field of Radiodiagnosis. His expertise includes proficiency in medical imaging, nuclear medicine, and color Duplex ultrasound. Dr. Basha has published over 40 scientific papers in peer-reviewed high-impact journals, demonstrating his ability to conduct rigorous research and disseminate findings effectively. He is also actively involved as a reviewer for esteemed international journals, showcasing his strong analytical abilities and attention to detail. Moreover, Dr. Basha’s Researcher ID, Scopus Author ID, ORCID, and Publons profile reflect his commitment to academic excellence and scholarly integrity. Overall, his comprehensive research skills underscore his dedication to advancing knowledge and innovation in Radiodiagnosis.

Publications

  1. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses
    • Authors: MAA Basha, MI Metwally, SA Gamil, HM Khater, SA Aly, AA El Sammak
    • Journal: European Radiology
    • Year: 2021
    • Citations: 86
  2. A novel method for COVID-19 diagnosis using artificial intelligence in chest X-ray images
    • Authors: YE Almalki, A Qayyum, M Irfan, N Haider, A Glowacz, FM Alshehri
    • Journal: Healthcare
    • Year: 2021
    • Citations: 65
  3. Does a combined CT and MRI protocol enhance the diagnostic efficacy of LI-RADS in the categorization of hepatic observations? A prospective comparative study
    • Authors: MAA Basha, MZ AlAzzazy, AF Ahmed, HY Yousef, SM Shehata
    • Journal: European Radiology
    • Year: 2018
    • Citations: 56
  4. The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study
    • Authors: MI Metwally, NA Zeed, EM Hamed, ASF Elshetry, RM Elfwakhry
    • Journal: European Radiology
    • Year: 2021
    • Citations: 51
  5. The validity and reproducibility of the Thyroid Imaging Reporting and Data System (TI-RADS) in categorization of thyroid nodules: Multicentre prospective study
    • Authors: Not specified
    • Journal: European Journal of Radiology
    • Year: 2019
    • Citations: 49
  6. Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10–20 mm) detected in the cirrhotic liver at …
    • Authors: MAA Basha, DAEA El Sammak, AA El Sammak
    • Journal: Clinical radiology
    • Year: 2017
    • Citations: 42
  7. Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement
    • Authors: MAABERRSA Ibrahim
    • Journal: European Radiology
    • Year: 2019
    • Citations: 36
  8. Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma> 3–< 5 cm
    • Authors: MMA Zaitoun, SB Elsayed, NA Zaitoun, RK Soliman, AH Elmokadem
    • Journal: International Journal of Hyperthermia
    • Year: 2021
    • Citations: 35
  9. 68Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement
    • Authors: O Basha, M.A.A., Hamed, M.A.G., Hussein
    • Journal: Abdominal Radiology
    • Year: 2019
    • Citations: 33
  10. Diagnostic performance of 18F-FDG PET/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study
    • Authors: MAA Basha, MAG Hamed, R Refaat, MZ AlAzzazy, MA Bessar
    • Journal: Japanese Journal of Radiology
    • Year: 2018
    • Citations: 32

 

 

Marie Skaalum Bloch | Medical Field Award | Best Researcher Award

Mrs. Marie Skaalum Bloch | Medical Field Award | Best Researcher Award

Master in Psychology at Psychologist Marie Skaalum Bloch, Denmark.

Marie Bloch is a dedicated and skilled psychologist with a strong background in psychotherapy, supervision, and training. She owns her own business, providing a range of mental health services since 2015. With experience as the Head of a department at a psychiatric clinic, she has demonstrated leadership and management skills, optimizing care and implementing best practices. Her work at the Center for Mentalization highlights her commitment to training and supervision, particularly in mentalization. Marie’s professional journey showcases her expertise in providing quality mental health care and her passion for advancing the field through research and training.

Professional Profiles:

Education:

Marie Skaalum Bloch completed her Master’s in Psychology at Aalborg University from 2007 to 2012. In November 2015, she received authorization as a psychologist from the Board of Psychology. In January 2019, she was approved as a specialist in psychodynamic psychotherapy by the Board of Psychology. Following this, in October 2019, she was approved as a specialist in psychotherapy by the Danish psychiatric department. In January 2021, she received approval as a supervisor from the Board of Psychology. Concurrently, in January 2021, she was also approved as an MBT (Mentalization-Based Treatment) supervisor and trainer by the Institute of Mentalization. Throughout her career, Marie Skaalum Bloch has demonstrated a commitment to advancing her expertise in psychology and psychotherapy, gaining recognition for her specialized skills and qualifications.

Experience:

Since 2015, psychologist Marie Bloch has owned her own business, where she provides therapy, supervision, and training services. From January 1, 2022, to May 1, 2023, she worked at the Center for Mentalization as a supervisor and instructor, primarily focusing on training and supervising staff in mentalization. Prior to this, from April 1, 2014, to December 31, 2021, Marie worked at the Ambulatorium for Angst og Personlighedspsykiatri, Klinik Nord, Brønderslev, an outpatient psychiatric clinic specializing in treating patients with anxiety and personality disorders. From April 1, 2019, to December 31, 2021, she served as the Head of the department, where she was responsible for management, optimization, improvement, implementation, supervision, and training. Before assuming this role, from April 1, 2014, to March 31, 2019, she worked as a clinical psychologist in the clinic, focusing on assessment, treatment, supervision, research, and staff training. Marie’s diverse roles and responsibilities demonstrate her expertise and commitment to providing high-quality mental health services.

Skills:

Marie Bloch is a skilled psychologist with a wealth of experience in psychotherapy, supervision, and training. She owns her own business, offering therapy, supervision, and training services since 2015. Her professional journey includes serving as the Head of the department at the Ambulatorium for Angst og Personlighedspsykiatri, Klinik Nord, Brønderslev, from 2019 to 2021, where she managed, optimized, and implemented strategies to improve patient care. Prior to this, she worked as a clinical psychologist at the same clinic from 2014 to 2019, focusing on assessment, treatment, and staff training. Marie has also contributed significantly to the field of mental health through her role at the Center for Mentalization, where she supervised and instructed staff with a focus on mentalization. Her diverse experiences and commitment to professional development make her a valuable asset in the field of psychology.